The psychiatric side-effects of rimonabant

2009227 citationsReviewdiamond Open Access

Authors

Fabrício A. Moreira · Universidade Federal de Minas Gerais

José Alexandre S. Crippa · National Council for Scientific and Technological Development

Abstract

Patients taking CB1 receptor antagonists should be carefully investigated for psychiatric side-effects. These drugs should not be prescribed for those already suffering from mental disorders. Nevertheless, the development of new compounds targeting the endocannabinoid system for the treatment of several conditions would be necessary and opportune.

Topics & Keywords

Cannabis and Cannabinoid Research Neurotransmitter Receptor Influence on Behavior Sleep and Wakefulness Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Brazilian Journal of Psychiatry

Volume 31, Issue 2, pp. 145-153

DOI: 10.1590/s1516-44462009000200012

Field-Weighted Citation Impact: 8.04